Showing results (881-890 of 904) with videos related to
Sort By:
Pageof 91
Biorxiv : the Preprint Server for Biology|January 4, 2022
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimenManon Nayrac, Mathieu Dubé, Gérémy Sannier, et al.Brain Plasticity (Amsterdam, Netherlands)|February 1, 2023
Proceedings from the Albert Charitable Trust Inaugural Workshop on 'Understanding the Acute Effects of Exercise on the Brain'Jill N Barnes, Jeffrey M Burns, Marcas M Bamman, et al.Experimental Dermatology|September 13, 2017
Proceeding report of the Symposium on Hidradenitis Suppurativa Advances (SHSA)Ali Mehdizadeh, Afsaneh Alavi, Raed Alhusayen, et al.Cell Reports|June 22, 2022
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimenManon Nayrac, Mathieu Dubé, Gérémy Sannier, et al.Journal of Medicinal Chemistry|April 27, 2012
Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitorsMark A Ashwell, Jean-Marc Lapierre, Christopher Brassard, et al.CJC Open|June 22, 2026
Investigating Physical Exercise and Cognitive Training Effects on Cognition and Brain Health in Men and Women with Heart Failure: The ReCARDIO TrialLouis Bherer, Florent Besnier, Christine Gagnon, et al.Biorxiv : the Preprint Server for Biology|March 24, 2021
A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responsesAlexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.Cell Host & Microbe|June 16, 2021
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responsesAlexandra Tauzin, Manon Nayrac, Mehdi Benlarbi, et al.Bioorganic & Medicinal Chemistry Letters|July 22, 2008
Efficient parallel synthesis of macrocyclic peptidomimeticsEric Marsault, Hamid R Hoveyda, René Gagnon, et al.The Journal of Clinical Investigation|February 26, 2021
Identification of SARS-CoV-2-specific immune alterations in acutely ill patientsRose-Marie Rébillard, Marc Charabati, Camille Grasmuck, et al.Pageof 91